Royma Tech (Suzhou) Precision Co., Ltd. designs industrial X‑ray and 3D CT inspection systems for nondestructive testing. Its automated inline CT platforms provide micron‑level defect detection for batteries, semiconductors, automotive, and electronics manufacturing.
Royma Tech (Suzhou) Precision Co., Ltd., founded in 2017 and headquartered in Suzhou, China, develops industrial computed tomography (CT) and X‑ray inspection systems for nondestructive testing across battery manufacturing, semiconductors, automotive, aerospace, and electronics. The company provides R&D, production, sales, leasing, and service solutions and operates R&D centers in Beijing and Singapore with offices in the United States and multiple Chinese cities. Royma’s mission is to improve manufacturing quality and safety through high‑resolution imaging, digital inspection workflows, and professional training via RoymaCT College.
Royma Tech develops industrial X‑ray and 3D CT systems that deliver micron to sub‑micron resolution for nondestructive inspection. Core capabilities include automated inline CT platforms, precision 2D X‑ray metrology, and artificial intelligence–enhanced image processing and defect classification. The company integrates high‑brightness X‑ray sources such as MetalJet options, automated material handling, and software for automated analysis and reporting. Early internal defect detection reduces scrap and warranty risk, supports safer products, and improves resource efficiency in manufacturing workflows.
Royma’s product portfolio includes 2D X‑ray systems (RMX3000, RMLVX1850), a horizontal CT series (RMCT1000–RMCT10000), planar CT (RMPCT5500), and at‑line/in‑line gantry CT (RMLCT7000, RMLCT7500). Systems are configurable for cylindrical, pouch, and prismatic lithium‑ion cells and for components used in aerospace, semiconductors, die casting, and consumer electronics. Key benefits are micron‑level defect detection, automated data workflows, and leasing or inspection‑as‑a‑service options.
Royma’s disclosed funding is approximately $27.5 million. Principal investors are strategic and financial partners that have supported R&D, increases in manufacturing capacity, product development, integration of advanced X‑ray sources and software, and international commercial expansion.
